Immunohistochemical staining seems mandatory for individualizing and shortening follow‐up in unilateral primary aldosteronism
Clinical Endocrinology · 2023
DOI: 10.1111/cen.14958 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, 2023. Verfasst von Hrafnhildur Gunnarsdottir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Iceland, Reykjavik, Iceland. Hauptthemen laut MEDLINE: Hyperaldosteronism, Immunohistochemistry. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Landspitali Research Fund.
Abstract (Originalsprache)
Objective
The clinical significance of immunohistochemistry (IHC) for unilateral primary aldosteronism (PA) has been unclear. Individualized follow‐up of PA patients could be in sight. Long‐term outcomes of patients, classified based on IHC, need further investigation. We aimed to assess long‐term clinical outcomes for unilateral PA, classifying patients based on IHC.
Design
A nationwide observational study, with up to 16 years follow‐up, executed in 2007–2016 at Landspitali University Hospital, tertiary referral center. Patients were diagnosed and treated in line with the current guidelines. Haematoxylin and eosin (H&E) tissue slides were stained using CYP11B1 and ‐B2 antibodies. All cases were re‐evaluated and classified according to the HISTALDO consensus. Outcomes were assessed using the PASO criteria. Patients All unilateral PA patients diagnosed in 2007‐2016 in Iceland, 26 patients aged 28–73 years, who underwent adrenalectomy, were included.
Measurements
Aldosterone, renin, and cortisol values, use and dosage of antihypertensives, potassium supplementation, blood pressure and serum potassium pre‐intervention and throughout follow‐up, and histopathology results post‐adrenalectomy.
Results
Following IHC, an aldosterone‐producing nodule was seen in 12 adrenals, an aldosterone‐producing adenoma in 10 and multiple aldosterone‐producing micronodules in four. IHC altered histopathology from previous H&E diagnosis in 23% (6/26) of the patients. In total, 81% (21/26) of the patients had partial clinical success. Eight percent (2/26) of the patients needed potassium supplementation during follow‐up. In the classical group, the AVS results were more determinative with significantly higher lateralization index (median 10.1 vs. 5.3, p = .04) and more contralateral suppression (median nondominant ratio 0.4 vs. 1.0, p = .03). One out of five patients with complete clinical success at 12 months post‐op had severe relapse later, the other four were normotensive without antihypertensives for up to 10 years.
Conclusions
We found IHC mandatory for accurate histopathologic diagnosis of PA. Our results support the importance of contralateral suppression when interpreting AVS results. Also, the study highlights the complicated assessment of clinical outcome and importance of aldosterone and renin measurements during follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
- Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland.
- Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
- Department of Radiology, Landspitali University Hospital, Reykjavik, Iceland.
- Department of Surgery, Landspitali University Hospital, Reykjavik, Iceland.
Förderung
- Landspitali Research Fund
Zitieren
APA
Gunnarsdottir, H., Agnarsson, B. A., Jonasdottir, S., Gudmundsson, J., Birgisson, G., & Sigurjonsdottir, H. A. (2023). Immunohistochemical staining seems mandatory for individualizing and shortening follow‐up in unilateral primary aldosteronism. Clinical Endocrinology. https://doi.org/10.1111/cen.14958
Vancouver
Gunnarsdottir H, Agnarsson BA, Jonasdottir S, Gudmundsson J, Birgisson G, Sigurjonsdottir HA. Immunohistochemical staining seems mandatory for individualizing and shortening follow‐up in unilateral primary aldosteronism. Clinical Endocrinology. 2023. doi:10.1111/cen.14958
BibTeX
@article{Gunnarsdottir2023,
author = {Gunnarsdottir, Hrafnhildur and Agnarsson, Bjarni A and Jonasdottir, Sigurros and Gudmundsson, Jon and Birgisson, Gudjon and Sigurjonsdottir, Helga A},
title = {Immunohistochemical staining seems mandatory for individualizing and shortening follow‐up in unilateral primary aldosteronism},
journal = {Clinical Endocrinology},
year = {2023},
doi = {10.1111/cen.14958}
}
EUVIMED